0000950170-23-066541.txt : 20231129 0000950170-23-066541.hdr.sgml : 20231129 20231129060110 ACCESSION NUMBER: 0000950170-23-066541 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231128 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231129 DATE AS OF CHANGE: 20231129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Marpai, Inc. CENTRAL INDEX KEY: 0001844392 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40904 FILM NUMBER: 231448295 BUSINESS ADDRESS: STREET 1: 615 CHANNELSIDE DRIVE STREET 2: SUITE 207 CITY: TAMPA STATE: FL ZIP: 33602 BUSINESS PHONE: 646-303-3483 MAIL ADDRESS: STREET 1: 615 CHANNELSIDE DRIVE STREET 2: SUITE 207 CITY: TAMPA STATE: FL ZIP: 33602 8-K 1 mrai-20231128.htm 8-K 8-K
false000184439200018443922023-11-282023-11-28

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 28, 2023

 

 

MARPAI, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40904

86-1916231

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

615 Channelside Drive, Suite 207

 

Tampa, Florida

 

33602

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 646 303-3483

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Class A Common Stock, par value $0.0001 per share

 

MRAI

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On May 31, 2023, Marpai, Inc. (the “Company”) received a notification letter (the “Notice) from The Nasdaq Stock Market LLC(“Nasdaq”) notifying the Company that for the last 30 consecutive business dayspreceding the date of the Notice, the Company’s Market Value of Listed Securities (“MVLS”) has been below the minimum of $35,000,000 required for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), Nasdaq provided the Company with 180 calendar days, or until November 27, 2023, to regain compliance with the MVLS Requirement.

On November 28, 2023, the Company received a letter (the “Delisting Notice”) from Nasdaq stating that, as a result of the Company not regaining compliance with the MVLS Requirement, its securities would be delisted from the Nasdaq Capital Market, effective as of the opening of the market on December 7, 2023. The Delisting Notice provided that the Company may appeal the delisting determination to a Hearings Panel. The Company intends to immediately file an appeal, which would suspend the delisting until the Hearings Panel has made a final determination.

Item 9.01 Financial Statements and Exhibits.

Exhibit
Number

Description

104

 

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

MARPAI, INC.

 

 

 

 

Date:

November 29, 2023

By:

/s/ Damien Lamendola

 

 

 

Name: Damien Lamendola
Title: Chief Executive Officer

 


EX-101.PRE 2 mrai-20231128_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.LAB 3 mrai-20231128_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications EX-101.SCH 4 mrai-20231128.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document And Entity Information
Nov. 28, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 28, 2023
Entity Registrant Name MARPAI, INC.
Entity Central Index Key 0001844392
Entity Emerging Growth Company true
Entity File Number 001-40904
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 86-1916231
Entity Address, Address Line One 615 Channelside Drive, Suite 207
Entity Address, City or Town Tampa
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33602
City Area Code 646
Local Phone Number 303-3483
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period true
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share
Trading Symbol MRAI
Security Exchange Name NASDAQ
XML 6 mrai-20231128_htm.xml IDEA: XBRL DOCUMENT 0001844392 2023-11-28 2023-11-28 false 0001844392 8-K 2023-11-28 MARPAI, INC. DE 001-40904 86-1916231 615 Channelside Drive, Suite 207 Tampa FL 33602 646 303-3483 false false false false Class A Common Stock, par value $0.0001 per share MRAI NASDAQ true true EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( "0P?5<'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " D,'U7?_LB.^T K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)OIVE%,'1S43PI""XHWD(RNQMLTI",M/OVIG&WB^@#"+EDYL\W MWT!Z'80>(S[',6 DB^EJ=H-/0H<-.Q % 9#T 9U*=4[XW-R-T2G*U[B'H/2' MVB.T37,##DD910H68!56(I.]T4)'5#3&$][H%1\^XU!@1@,.Z-!3 EYS8'*9 M&([ST,,%L, (HTO?!30KL53_Q)8.L%-R3G9-3=-43UW)Y1TXO#T]OI1U*^L3 M*:\QOTI6T#'@AITGOW9W]]L')MNF[2K.J_9VR[EH\KE^7UQ_^%V$W6CLSOYC MX[.@[.'7OY!?4$L#!!0 ( "0P?5>97)PC$ 8 )PG 3 >&PO=&AE M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X? MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@ MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1 MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?= MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%, M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SC MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_ M+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE" M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT ML@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3 M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.' M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\ M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^ M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?! M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83 M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL' M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5 MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$% @ M)#!]5\:4GRIX! -Q$ !@ !X;"]W;W)K,;TA2QX#M\L MI,J8@5.U='6A.$NJH"QU?<_KN1D3N3,:5)]-U6@@2Y.*G$\5T666,?5QRU.Y M&3K4V7_P(I8K8S]P1X."+?F,F]^+J8(SMU9)1,9S+61.%%\,G8C>W/J7-J"Z MX@_!-_K@F-A;F4OY9D\FR=#Q+!%/>6RL!(.W-1_S-+5*P/'/3M2I?],&'A[O MU1^JFX>;F3/-QS+])A*S&CI]AR1\P,<-& R4W1-FK05+=: M10.L;7;"8#QTH7,W5FCNC'[ZC/>]GA"^H^0),O4G@ZT?!V^#P\/[Y%P0B MK"%"5"4"@J2B>$C9LHT"CU^P5'.$X[+FN#PM&5.NA+0%E1 HR]:\X$IU&775 M4:]&ZZ&"N]I^X4MA*PD8GUG6"H;K/$4OTVAR1B;/XPL$ZZK&NCH%:PQ)4RR% MK9?P=_*%?[2!X4J>Y]%^& ;7/H+5K['ZIV#=9UPM1;XDOT"\69&QS J6M\+A M>D:56'U=UUC7IV ]B)23YS*;<]6&@FM FLY#[]H+$1[J-?;IG4(TR6.I"JDJ MTSPC,P-%3Z2"A)6PL+"^,FFMM0[UNWL,\L#CZ2F0K^R=3!*H-+$0<46*)+%# MLM\[I]>TYP<4(VQ,GJ(>O2>,D@0<6I_M#\@C7$>^YNVYPR5[])*,5RS/>:I% MPLF=@O8/2U,*6!K?N\*X&_.GN'U_YA[;,UCW5[EI[YVXW"N#_86!-0V!XH[^ M&:RNR*F2:Y''[1G%-1\>,;2F1U#OUB^"\?8X"B[0"WL82-,6*.[FCS*&G$Q7,L> MOVD&/F[74\7/8T@/A_VUG0EA+(/I]>MBT;Y^'7J=9$T'\'&[_A_91.L2R#H! M<=E.P(,I_Z0&/Z/N[1^]3!$L?0E9?\Z/S=(?0< MS>ZBW]J8W(/'8/N7PA.SPZLF*5^ DG=Q!<)J^Y2^/3&RJ)Z,Y]+ ?H!OPL0( .(, - M >&PO9KEMWDOSAR+DCO9*ZW="C M<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+ M#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\ M0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9 M%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.'36-/+T08I: M*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#S MGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[ MBK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1 MS;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG M_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P M%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/ MK O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8* \^>Q\ETWLJ.?]74_P$4$L#!!0 ( "0P?5>7 MBKL

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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports mrai-20231128.htm mrai-20231128.xsd mrai-20231128_lab.xml mrai-20231128_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "mrai-20231128.htm": { "nsprefix": "mrai", "nsuri": "http://www.marpaihealth.com/20231128", "dts": { "inline": { "local": [ "mrai-20231128.htm" ] }, "schema": { "local": [ "mrai-20231128.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "mrai-20231128_lab.xml" ] }, "presentationLink": { "local": [ "mrai-20231128_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_58b2ad77-0b94-4970-98cf-6885d9784515", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mrai-20231128.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_58b2ad77-0b94-4970-98cf-6885d9784515", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mrai-20231128.htm", "first": true, "unique": true } } }, "tag": { "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.marpaihealth.com/20231128/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0000950170-23-066541-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-066541-xbrl.zip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